Package 31722-841-30

{"route": ["ORAL"], "spl_id": "3de3bb2e-97bf-4a59-e063-6294a90a7744", "openfda": {"upc": ["0331722841306", "0331722844307", "0331722842303", "0331722843300"], "unii": ["4U07F515LG"], "rxcui": ["825421", "825427", "884617", "1245001"], "spl_set_id": ["e913cd11-f5fb-4ebe-81c7-0c5626b52cfd"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (31722-841-30)", "package_ndc": "31722-841-30", "marketing_start_date": "20250513"}], "brand_name": "ELTROMBOPAG", "product_id": "31722-841_3de3bb2e-97bf-4a59-e063-6294a90a7744", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Increased Megakaryocyte Maturation [PE]", "Increased Platelet Production [PE]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Thrombopoietin Receptor Agonist [EPC]", "Thrombopoietin Receptor Agonists [MoA]", "UGT1A1 Inhibitors [MoA]", "UGT1A3 Inhibitors [MoA]", "UGT1A4 Inhibitors [MoA]", "UGT1A6 Inhibitors [MoA]", "UGT1A9 Inhibitors [MoA]", "UGT2B15 Inhibitors [MoA]", "UGT2B7 Inhibitors [MoA]"], "product_ndc": "31722-841", "generic_name": "ELTROMBOPAG", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ELTROMBOPAG", "active_ingredients": [{"name": "ELTROMBOPAG OLAMINE", "strength": "12.5 mg/1"}], "application_number": "ANDA206788", "marketing_category": "ANDA", "marketing_start_date": "20250513", "listing_expiration_date": "20261231"}